NGM BIO HOLDINGS, INC.

Profile

Company Names

NGM BIO HOLDINGS, INC.

Addresses

611 GATEWAY BLVD., SUITE 540, SOUTH SAN FRANCISCO, CA 94080

333 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-243-5555

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2024

State Incorporated:

DELAWARE

Total Amount Raised:

$142,039,949.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-07-05 
$142,039,949.00 
$142,039,949.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DIANA 
PENG 
BOCKUS 
EXECUTIVE OFFICER, DIRECTOR
NGM BIO HOLDINGS, INC.
KARA 
 
CALHOUN 
EXECUTIVE OFFICER
NGM BIO HOLDINGS, INC.
DAVID 
 
GOEDDEL 
DIRECTOR
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PELOTON THERAPEUTICS, INC.   |  NURIX, INC.   |  NEURONA THERAPEUTICS INC   |  IGENICA BIOTHERAPEUTICS, INC   |  FLX BIO, INC.   |  EXONICS THERAPEUTICS, INC.   |  SURROZEN, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  HEXAGON BIO INC.   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  NGM BIO HOLDINGS, INC.
SHELLY 
D. 
GUYER 
DIRECTOR
IRHYTHM TECHNOLOGIES INC   |  IRHYTHM TECHNOLOGIES, INC.   |  VERACYTE, INC.   |  NGM BIO HOLDINGS, INC.
CAROLE 
 
HO 
DIRECTOR
BEAM THERAPEUTICS INC.   |  DENALI THERAPEUTICS INC.   |  NGM BIO HOLDINGS, INC.
DANIEL 
 
KAPLAN 
EXECUTIVE OFFICER
POWERHOUSE DYNAMICS, INC.   |  PMG 11TH STREET HOLDINGS, LLC   |  PMG BLOCK 17 PREFERRED, LLC   |  PMG BLOCK 17 INVESTORS, LLC   |  PMG CHERRY CREEK PREFERRED, LLC   |  PMG CHERRY CREEK INVESTORS, LLC   |  PMG BLOCK 17 COMMON, LLC   |  NGM BIO HOLDINGS, INC.   |  PMG 11TH STREET NEW PREFERRED, LLC   |  PMG 900 INTRACOASTAL INVESTORS, LLC   |  PMG 900 INTRACOASTAL HOLDINGS, LLC   |  PMG RIVERFRONT PORTFOLIO INVESTORS, LLC   |  PMG RIVERFRONT HOLDINGS, LLC   |  PMG 11TH STREET INVESTORS, LLC   |  HEARTSTONE FARM, INC.
TIM 
 
KUTZKEY 
DIRECTOR
CARMOT THERAPEUTICS INC.   |  CYTERIX PHARMACEUTICALS INC.   |  PELOTON THERAPEUTICS, INC.   |  NEURONA THERAPEUTICS INC   |  KALLYOPE, INC.   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  SURROZEN, INC.   |  NEURONA THERAPEUTICS, INC   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  SITE TX, INC.   |  NILO THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
HSIAO 
D. 
LIEU 
EXECUTIVE OFFICER
NILE THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
ROGER 
M. 
PERLMUTTER 
DIRECTOR
EIKON THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
VALERIE 
 
PIERCE 
EXECUTIVE OFFICER
NGM BIO HOLDINGS, INC.
WILLIAM 
J. 
RIEFLIN 
DIRECTOR
XENOPORT INC   |  NGM BIOPHARMACEUTICALS INC   |  FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
JEAN-FREDERIC 
 
VIRET 
EXECUTIVE OFFICER
ANESIVA, INC.   |  NGM BIO HOLDINGS, INC.
DAVID 
J. 
WOODHOUSE 
EXECUTIVE OFFICER, DIRECTOR
NGM BIO HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-05 
2024-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#